↓ Skip to main content

Dove Medical Press

Article Metrics

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Overview of attention for article published in Biologics: Targets & Therapy, July 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
15 Mendeley
Title
Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Published in
Biologics: Targets & Therapy, July 2012
DOI 10.2147/btt.s27343
Pubmed ID
Authors

Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Olga Kaloudi, Emanuele Cassarà, Massimo Susini, Ivo Lenzetti

Abstract

To evaluate the long-term efficacy of infliximab in patients with refractory Behçet's disease (BD)-associated and idiopathic posterior uveitis (PU).

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 27%
Professor > Associate Professor 3 20%
Other 2 13%
Student > Ph. D. Student 1 7%
Professor 1 7%
Other 4 27%
Readers by discipline Count As %
Medicine and Dentistry 13 87%
Immunology and Microbiology 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2012.
All research outputs
#3,107,596
of 4,506,762 outputs
Outputs from Biologics: Targets & Therapy
#86
of 114 outputs
Outputs of similar age
#48,900
of 75,174 outputs
Outputs of similar age from Biologics: Targets & Therapy
#6
of 11 outputs
Altmetric has tracked 4,506,762 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 114 research outputs from this source. They receive a mean Attention Score of 2.2. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 75,174 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.